- active not recruitingPHASE3
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
This study looks at a new drug, abemaciclib, combined with standard treatment for prostate cancer that has spread. We want to see if this combination can stop the cancer from getting worse for longer in men whose cancer is still responding to hormone therapy.
United States · Argentina · Australia - recruitingPHASE4
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
This study looks at whether a medicine called Dexmedetomidine can help prevent memory problems and confusion after heart surgery. Researchers want to see if it improves recovery and reduces how long people stay in hospital.
Canada - active not recruitingPHASE2
Omalizumab to Accelerate a Symptom-driven Multi-food OIT
This study looks at how a drug called omalizumab can help people with serious food allergies take part in a food desensitisation programme more quickly. It's for people aged 6-25 who are allergic to multiple foods.
Canada - recruitingPHASE3
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
This study looks at a new treatment called NT 201 for prominent neck bands (platysma prominence). It compares NT 201 to a dummy treatment to see if it's safe and effective for adults with moderate to severe neck bands.
Germany · Poland · Spain